RecruitingNCT00707694

The Longevity Genes in Founder Populations Project

Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population


Sponsor

Albert Einstein College of Medicine

Enrollment

2,000 participants

Start Date

Jul 1, 1998

Study Type

OBSERVATIONAL

Conditions

Summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.


Eligibility

Min Age: 65 Years

Inclusion Criteria3

  • Ashkenazi Jewish, age 95+,
  • Offspring of person age 95+,
  • Offspring of parents who died age 70 or younger.

Exclusion Criteria1

  • Non-Ashkenazis

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Private Homes

New York, New York, United States

Hebrew Home Riverdale

Riverdale, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00707694


Related Trials